Description Module

Description Module

The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.

Description Module path is as follows:

Study -> Protocol Section -> Description Module

Description Module


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-25 @ 1:24 AM
NCT ID: NCT07256093
Brief Summary: The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) can reduce dysfunctional attitudes and difficulties in emotion regulation among university students in Malaysia.The main questions it aims to answer are: * Will participants who receive ACT show statistically significant reduction in dysfunctional attitudes scores compared to those in the control group? * Will participants who receive ACT show statistically significant reduction in difficulties in emotion regulation scores compared to those in the control group? * Will participants who receive ACT show statistically significant reduction in dysfunctional attitudes scores from pre-test to intermediate-test and from pre-test to post-test? * Will participants who receive ACT show statistically significant reduction in difficulties in emotion regulation scores from pre-test to intermediate test and from pre-test to post-test? Researchers will compare ACT group to a waitlist control group to see if ACT work to reduce dysfunctional attitudes and difficulties in emotion regulation. Participants in the ACT group will * attend six weekly individual sessions of ACT intervention (1 hour per session) conducted online * complete the outcome measures at three different time points (week 1, week 3, and week 6) Meanwhile, participants in the waitlist control group * will not receive any intervention during the data collection period * will be asked to complete same outcome measures at three different time points (week 1, week 3, and week 6)
Study: NCT07256093
Study Brief:
Protocol Section: NCT07256093